Regeneron Pharmaceuticals, Inc. REGN reported fourth-quarter 2024 earnings per share (EPS) of $12.07, which beat the Zacks Consensus Estimate of $11.62. The company recorded an EPS of $11.86 in the ...

Trade war and tariff headlines seem to be rolling in by the hour, adding a significant degree of uncertainty to this market and rattling investors. While some stocks and sectors struggle under the ...